Serum levels of interleukin-33 and its soluble form receptor (sST2) are associated with cognitive performance in patients with schizophrenia (Q51167250)
Jump to navigation
Jump to search
scientific article published on 14 January 2017
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Serum levels of interleukin-33 and its soluble form receptor (sST2) are associated with cognitive performance in patients with schizophrenia |
scientific article published on 14 January 2017 |
Statements
Serum levels of interleukin-33 and its soluble form receptor (sST2) are associated with cognitive performance in patients with schizophrenia (English)
1 reference
Salvina Maria de Campos-Carli
Aline Silva Miranda
Ingrid Caroline Silva Dias
Amanda de Oliveira
Breno Fiuza Cruz
Érica Leandro Marciano Vieira
Izabela Guimarães Barbosa
João VinÃcius Salgado
14 January 2017
1 reference